- Trials with a EudraCT protocol (395)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (69)
395 result(s) found for: aspirin.
Displaying page 2 of 20.
| EudraCT Number: 2009-017176-25 | Sponsor Protocol Number: WMLREC and BBC LREC | Start Date*: 2010-09-08 |
| Sponsor Name:Sandwell and West Birmingham NHS Trust | ||
| Full Title: Aspirin resistance and heart disease | ||
| Medical condition: Index group 1 : coronary artery disease Index group 2: atrial fibrillation Control group 1: Diabetes/hypertension/hypercholesterolaemia Control group 2: Healthy subjects | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (GB - no longer in EU/EEA) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2012-001270-28 | Sponsor Protocol Number: Protokół_ASAPOL_wersja4_z_dnia_27_0 | Start Date*: 2012-09-21 |
| Sponsor Name:Medical Centre of Postgraduate Education, Poland | ||
| Full Title: The Risk of Bleeding After Removal of Large Colorectal Polyps in Patients Continuing or Discontinuing on Aspirin: a Multicenter, Double-blind, Placebo-controlled, Randomized Clinical Trial | ||
| Medical condition: Bleeding after removal large colorectal polyps in patients taking aspirin in profilactic doses or placebo | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: PL (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2007-000942-11 | Sponsor Protocol Number: 140207 | Start Date*: 2008-04-30 |
| Sponsor Name:Medizinische Universität Wien/ Universitätsklinik für Innere Medizin II/ Angiologie und Kardiologie | ||
| Full Title: Vienna-Resistance to Antithrombotic Therapy (REACT) | ||
| Medical condition: Resistance to Aspirin and Clopidogrel | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2019-003679-20 | Sponsor Protocol Number: DUAL-PAD_v3 | Start Date*: 2020-03-11 |
| Sponsor Name:Radboudumc | ||
| Full Title: DUAL pathway inhibition (low-dose rivaroxaban and aspirin) as compared to aspirin only to improve endothelial function in peripheral artery disease (PAD) | ||
| Medical condition: symptomatic or stable pheripheral artery disease | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-000968-30 | Sponsor Protocol Number: RC31/19/0509 | Start Date*: 2021-04-13 | |||||||||||
| Sponsor Name:CHU Toulouse | |||||||||||||
| Full Title: ASPirin in Immune thRombocytopenia patients with cardiovascular disEase | |||||||||||||
| Medical condition: Immune thrombocytopenia with cardiovascular disease | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: FR (Trial now transitioned) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2014-002564-32 | Sponsor Protocol Number: 14043DMcA-AS | Start Date*: 2014-10-27 |
| Sponsor Name:Belfast Health and Social Care Trust | ||
| Full Title: ASpirin as a Treatment for ARDS (STAR) trial: a randomised, double-blind, allocation concealed, placebo-controlled phase 2 trial. | ||
| Medical condition: Acute respiratory distress syndrome | ||
| Disease: | ||
| Population Age: Under 18, Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2007-004354-90 | Sponsor Protocol Number: 270884 | Start Date*: 2007-10-03 |
| Sponsor Name:academisch ziekenhuis Maastricht | ||
| Full Title: Effecten van aspirine op de plaatjesfunctie bij gezonde vrijwillige proefpersonen. | ||
| Medical condition: Aspirin resistance | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2011-002233-19 | Sponsor Protocol Number: ASA-CABG-01 | Start Date*: 2011-10-14 |
| Sponsor Name:Karolinska Institute | ||
| Full Title: Antiplatelet effects of once versus twice daily dosing of aspirin after coronary artery bypass grafting | ||
| Medical condition: Patients having successfully undergone coronary artery bypass graft (CABG) surgery | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2010-024448-13 | Sponsor Protocol Number: 010884 | Start Date*: 2011-02-18 | |||||||||||
| Sponsor Name:Netherlands Heart Foundation | |||||||||||||
| Full Title: Effects of low-dose aspirin taken at bedtime on blood pressure of subjects with who use aspirin for prevention of recurrent cardiovascular events: the Aspirin In Reduction of Tension II (ASPIRETENS... | |||||||||||||
| Medical condition: The medical condition to be investigated is hypertension | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: NL (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2004-005136-76 | Sponsor Protocol Number: ASINC101C | Start Date*: 2005-05-02 |
| Sponsor Name:Professor Christina Eintrei,Institution of Medical & Health, Section of Anesthesiology | ||
| Full Title: Aspirin in noncardiac surgery | ||
| Medical condition: Patients with cardiovascular risk factors undergoing elective non-cardiac surgery of high or intermediate risk. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: SE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2018-000017-20 | Sponsor Protocol Number: ASS-Metamizol-DDI | Start Date*: 2018-07-17 |
| Sponsor Name:Universitäts-Herzzentrum Freiburg • Bad Krozingen | ||
| Full Title: Antiplatelet effect of acetylsalicylic acid in patients after cardiac surgery: Impact of dipyrone (metamizole) | ||
| Medical condition: Antithrombotic therapy after surgical replacement of stenotic heart valve by a bioprosthesis or mitral valve repair | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2008-001620-31 | Sponsor Protocol Number: CZB/4/622 | Start Date*: 2009-09-14 |
| Sponsor Name:NHS Highland | ||
| Full Title: Glutathione Status in Platelets From Patients With Type 2 Diabetes: Therapeutic Potential of N-acetylcysteine to Help Prevent Platelet Hyperaggregability | ||
| Medical condition: Platelet Aggregation in type 2 diabetes | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2013-003187-31 | Sponsor Protocol Number: GN09CA403 | Start Date*: 2015-03-19 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sponsor Name:NHS Greater Glasgow & Clyde | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Full Title: Misoprostol for the Healing of Small Bowel Ulceration in Patients with Obscure Blood Loss while Taking Low-Dose Aspirin or Non-Steroidal Anti-inflammatory Drugs [MASTERS Trial] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Medical condition: Small bowel ulcers associated with iron deficiency anaemia or obscure blood loss in patients using aspirin or non-steroidal anti-inflammatory drugs | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Trial protocol: GB (Completed) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Trial results: View results | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EudraCT Number: 2014-002004-24 | Sponsor Protocol Number: CV185-316 | Start Date*: 2017-02-08 | |||||||||||||||||||||
| Sponsor Name:Bristol-Myers Squibb International Corporation | |||||||||||||||||||||||
| Full Title: An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients with Atrial Fibrillatio... | |||||||||||||||||||||||
| Medical condition: Atrial Fibrillation and Acute Coronary Syndrome and/or Percutaneous Coronary Intervention | |||||||||||||||||||||||
|
|||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
| Trial protocol: NO (Completed) BG (Completed) AT (Completed) BE (Completed) DK (Completed) NL (Completed) PL (Completed) PT (Completed) ES (Completed) CZ (Completed) DE (Completed) SE (Completed) SK (Completed) GB (Completed) | |||||||||||||||||||||||
| Trial results: View results | |||||||||||||||||||||||
| EudraCT Number: 2019-004889-18 | Sponsor Protocol Number: 1.3 | Start Date*: 2022-04-21 |
| Sponsor Name:Medical University of Vienna | ||
| Full Title: Effect of Dupilumab in patients with aspirin-exacerbated respiratory disease (AERD) -A single-center prospective pilot study | ||
| Medical condition: Aspirin-exacerbated respiratory disease (AERD), also known as Samter's Triad or Widal's triad, comprises the triad of allergic asthma, chronic rhinosinusitis with nasal polyps (CRswNP) and nonstero... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2012-002755-42 | Sponsor Protocol Number: 1069/12 | Start Date*: 2012-11-06 | |||||||||||
| Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI | |||||||||||||
| Full Title: OBESITY AND ASPIRIN RESPONSIVENESS | |||||||||||||
| Medical condition: OBESITY | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2015-003220-31 | Sponsor Protocol Number: 54463 | Start Date*: 2016-06-21 |
| Sponsor Name:VU medical center, Amsterdam | ||
| Full Title: Low dose aspirin in the Prevention of Recurrent Spontaneous Preterm Labour – the APRIL study | ||
| Medical condition: Prevention of recurrent spontaneous preterm birth | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2004-003836-77 | Sponsor Protocol Number: OCTO-003 | Start Date*: 2008-12-09 |
| Sponsor Name:University of Oxford | ||
| Full Title: AspECT - A phase III, randomised study of aspirin and esomeprazole chemoprevention in Barrett's metaplasia & oesophagitis. | ||
| Medical condition: Barrett's Metaplasia | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2007-006686-32 | Sponsor Protocol Number: EC07/90573 | Start Date*: 2008-05-22 |
| Sponsor Name:FUNDACIÓN INVESTIGACIÓN BIOMEDICA DEL HOSPITAL CLINICO SAN CARLOS | ||
| Full Title: Identificación de biomarcadores proteicos asociados a resistencia a la aspirina y a tienopiridinas en pacientes con cardiopatía isquémica establecida. (ESTUDIO BIRAT). Identification of new protei... | ||
| Medical condition: To determine proteins in plasma, leukocytes and platelets associated with aspirin resistance syndrome in stable coronary artery disease patients that may allow us to identify them.It is probably th... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2005-005292-15 | Sponsor Protocol Number: H7T-MC-TABR & TABR (1) | Start Date*: 2006-03-02 | |||||||||||
| Sponsor Name:Eli Lilly and Company Ltd. | |||||||||||||
| Full Title: A Pharmacokinetic and Pharmacodynamic Comparison of Prasugrel (LY640315) versus Clopidogrel in Subjects with Stable Atherosclerosis | |||||||||||||
| Medical condition: Stable atherosclerosis | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: SE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
